Gundeep Singh Dhillon, MD
Critical Care (Intensivists) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dhillon’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C51712 · Current
Licensed to practise in California · since 2004 · expires 2028-04-30 · Punjab University, Christian Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$164,674
Medicare paid this office $164,674 for 198 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 103 | $87,319 | $106 |
| Critical care, first 30-74 minutes | 42 | $45,393 | $186 |
| Long return visit (40+ min) | 101 | $16,665 | $113 |
| Hospital discharge day management, 30 minutes or less | 45 | $4,199 | $74 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 15 | $1,417 | $67 |
Who their Medicare patients are
198 Original Medicare patients in 2024. Average age 65 · Under 65 35% · Women 47% · Also on Medicaid 40% · Health risk score 3.77. Sicker patients than 9 in 10 peers; the typical critical care (intensivists) clinician is at 2.58.
Conditions among them: High blood pressure 75% · Chronic kidney disease 66% · Diabetes 60% · COPD 52% · Coronary heart disease 43% · Atrial fibrillation 41% · Heart failure 39% · Depression 34% · Stroke 20% · Dementia 13% · Cancer 11%.
The office billed $912,757, Medicare allowed $210,375 and paid $164,674; for 1,393 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 198 | 1,393 | 65 | 3.77 | $912,757 | $164,674 |
| 2023 | 184 | 1,049 | 67 | 3.67 | $857,175 | $137,871 |
| 2022 | 189 | 1,492 | 66 | 3.39 | $929,242 | $170,857 |
| 2021 | 165 | 1,187 | 66 | 3.46 | $918,769 | $151,709 |
| 2020 | 203 | 1,579 | 67 | 3.16 | $964,224 | $189,082 |
| 2019 | 255 | 1,450 | 64 | 3.34 | $743,731 | $163,380 |
| 2018 | 235 | 1,379 | 63 | 3.42 | $768,066 | $159,035 |
| 2017 | 234 | 1,651 | 63 | 3.41 | $842,742 | $180,149 |
| 2016 | 231 | 965 | 65 | 3.10 | $681,767 | $120,858 |
| 2015 | 248 | 1,474 | 63 | 3.08 | $751,779 | $163,445 |
| 2014 | 240 | 1,187 | 62 | 3.06 | $610,619 | $133,872 |
| 2013 | 220 | 1,150 | 61 | 2.92 | $656,652 | $135,919 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $58,564 | $109 |
| Critical care, first 30-74 minutes | 73 | $55,985 | $192 |
| Long return visit (40+ min) | 70 | $13,013 | $130 |
| Hospital discharge day management, 30 minutes or less | 32 | $2,676 | $76 |
| Aspiration of initial secretion of lung airway using an endoscope | 13 | $1,676 | $105 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 17 | $1,420 | $55 |
2022: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $76,298 | $94 |
| Critical care, first 30-74 minutes | 74 | $51,284 | $194 |
| Long return visit (40+ min) | 100 | $26,698 | $122 |
| Hospital discharge day management, 30 minutes or less | 39 | $4,074 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $3,902 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,763 | $188 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $2,089 | $99 |
2021: 5 services
| Critical care, first 30-74 minutes | 56 | $65,124 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $58,735 | $95 |
| Long return visit (40+ min) | 79 | $18,319 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,701 | $185 |
| Hospital discharge day management, 30 minutes or less | 26 | $2,395 | $68 |
2020: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 92 | $77,979 | $97 |
| Critical care, first 30-74 minutes | 86 | $61,949 | $201 |
| Long return visit (40+ min) | 103 | $28,559 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $7,218 | $180 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 19 | $4,165 | $122 |
| Hospital discharge day management, 30 minutes or less | 35 | $3,975 | $70 |
| Long return visit (40+ min) | 14 | $1,494 | $107 |
2019: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $67,229 | $94 |
| Critical care, first 30-74 minutes | 90 | $45,393 | $197 |
| Long return visit (40+ min) | 143 | $34,616 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $7,342 | $184 |
| Hospital discharge day management, 30 minutes or less | 34 | $2,972 | $68 |
2018: 6 services
| Critical care, first 30-74 minutes | 80 | $55,024 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $46,800 | $93 |
| Long return visit (40+ min) | 141 | $41,300 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,743 | $169 |
| Hospital discharge day management, 30 minutes or less | 32 | $3,076 | $67 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 18 | $2,126 | $112 |
2017: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $66,271 | $93 |
| Long return visit (40+ min) | 136 | $46,567 | $98 |
| Critical care, first 30-74 minutes | 69 | $44,553 | $196 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $7,385 | $176 |
| Hospital discharge day management, 30 minutes or less | 43 | $4,240 | $66 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 18 | $3,083 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,203 | $65 |
2016: 6 services
| Critical care, first 30-74 minutes | 96 | $56,552 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $26,708 | $92 |
| Long return visit (40+ min) | 102 | $24,763 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,366 | $175 |
| Hospital discharge day management, 30 minutes or less | 24 | $2,301 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,350 | $64 |
2015: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $53,888 | $93 |
| Critical care, first 30-74 minutes | 77 | $42,839 | $197 |
| Long return visit (40+ min) | 127 | $39,150 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $10,291 | $174 |
| Hospital discharge day management, 30 minutes or less | 55 | $5,303 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $3,172 | $65 |
| New patient visit (60+ min) | 13 | $1,909 | $147 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,463 | $122 |
2014: 7 services
| Critical care, first 30-74 minutes | 85 | $41,049 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 84 | $39,650 | $92 |
| Long return visit (40+ min) | 116 | $27,431 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $11,318 | $180 |
| Hospital discharge day management, 30 minutes or less | 44 | $4,421 | $65 |
| New patient visit (60+ min) | 12 | $1,680 | $140 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 14 | $1,475 | $105 |
2013: 5 services
| Critical care, first 30-74 minutes | 76 | $51,677 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $42,497 | $89 |
| Long return visit (40+ min) | 97 | $20,968 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $10,858 | $175 |
| Hospital discharge day management, 30 minutes or less | 33 | $2,435 | $64 |
Medicaid work
$22,124 in 2024
Medicaid paid $22,124 for 450 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 358 | $16,685 |
| Long return visit (40+ min) | 92 | $5,438 |
| 2024 | 450 | 2 | 29 | $22,124 |
| 2023 | 499 | 3 | 23 | $46,239 |
| 2022 | 586 | 3 | 34 | $22,018 |
| 2021 | 825 | 7 | 22 | $45,207 |
| 2020 | 154 | 3 | 21 | $8,388 |
| 2019 | 255 | 3 | 17 | $14,497 |
| 2018 | 205 | 2 | 22 | $13,435 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 205 | $34,412 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 250 | $10,126 |
| Long return visit (40+ min) | 44 | $1,700 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 423 | $11,179 |
| Long return visit (40+ min) | 138 | $8,015 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 25 | $2,824 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 183 | $23,313 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 470 | $17,631 |
| Long return visit (40+ min) | 58 | $3,435 |
| COMPREHENSIVE METABOLIC PANEL | 43 | $323 |
| Measurement of tacrolimus | 24 | $249 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 24 | $141 |
| Measurement of magnesium | 23 | $114 |
2020
| Long return visit (40+ min) | 38 | $3,054 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 90 | $3,008 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 26 | $2,326 |
2019
| Long return visit (40+ min) | 80 | $5,914 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 144 | $5,793 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 31 | $2,789 |
2018
| Long return visit (40+ min) | 150 | $10,339 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 55 | $3,096 |
Drugs they prescribed that Part D paid
$1,045,453
Pharmacies billed $1,045,453 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,297) in 2024. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 0%.
3,062 generic and 220 brand-name prescriptions · $1,045,453 in drug cost · 448 antibiotic prescriptions to 85 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Posaconazole | 181 | $155,880 | $861 |
| Cresemba | 17 | $127,684 | $7,511 |
| Prevymis | 14 | $98,332 | $7,024 |
| Everolimus | 42 | $40,467 | $964 |
| Atovaquone | 65 | $33,790 | $520 |
See all 52 drugs
| Posaconazole | 181 | $155,880 | $861 |
| Cresemba | 17 | $127,684 | $7,511 |
| Prevymis | 14 | $98,332 | $7,024 |
| Everolimus | 42 | $40,467 | $964 |
| Atovaquone | 65 | $33,790 | $520 |
| Eliquis | 31 | $29,572 | $954 |
| Valganciclovir | 159 | $28,035 | $176 |
| Itraconazole | 98 | $27,396 | $280 |
| Breo Ellipta | 15 | $8,970 | $598 |
| Januvia | 16 | $8,690 | $543 |
| Mycophenolate Mofetil | 37 | $5,666 | $153 |
| Tacrolimus | 81 | $5,345 | $66 |
| Clotrimazole | 80 | $3,175 | $40 |
| Acyclovir | 255 | $2,788 | $11 |
| Budesonide-Formoterol | 11 | $2,296 | $209 |
| Pantoprazole | 298 | $1,952 | $7 |
| Sodium Polystyrene Sulfonate | 20 | $1,596 | $80 |
| Wixela Inhub | 16 | $1,560 | $98 |
| Fluticasone-Salmeterol | 13 | $1,522 | $117 |
| Sps | 12 | $1,339 | $112 |
| Rosuvastatin | 140 | $1,197 | $9 |
| Sulfamethoxazole-Trimethoprim | 279 | $1,181 | $4 |
| Nystatin | 31 | $1,138 | $37 |
| Azithromycin | 114 | $1,069 | $9 |
| Prednisone | 156 | $949 | $6 |
| Ondansetron Odt | 29 | $498 | $17 |
| Fluticasone Propionate | 48 | $447 | $9 |
| Warfarin | 38 | $427 | $11 |
| Gabapentin | 36 | $383 | $11 |
| Mirtazapine | 47 | $373 | $8 |
| Pravastatin | 44 | $366 | $8 |
| Amlodipine Besylate | 100 | $351 | $4 |
| Carvedilol | 41 | $317 | $8 |
| Levetiracetam | 12 | $309 | $26 |
| Metoprolol | 98 | $309 | $3 |
| Roflumilast | 12 | $292 | $24 |
| Potassium Chloride | 28 | $278 | $10 |
| Famotidine | 43 | $276 | $6 |
| Tamsulosin | 23 | $252 | $11 |
| Doxycycline Hyclate | 13 | $193 | $15 |
| Omeprazole | 21 | $164 | $8 |
| Levothyroxine | 34 | $152 | $4 |
| Glipizide Er | 12 | $87 | $7 |
| Duloxetine | 14 | $76 | $5 |
| Amoxicillin | 31 | $70 | $2 |
| Metoprolol | 14 | $65 | $5 |
| Furosemide | 23 | $56 | $2 |
| Chlorthalidone | 12 | $48 | $4 |
| Alendronate | 15 | $46 | $3 |
| Folic Acid | 11 | $37 | $3 |
| Atorvastatin | 20 | $37 | $2 |
| Escitalopram | 11 | $31 | $3 |
Year by year
| 2024 | 3,297 | 185 | 0% (0) | 7% | $1,045,453 |
| 2023 | 3,054 | 168 | None | 5% | $1,120,860 |
| 2022 | 3,527 | 173 | 0% (0) | None | $1,189,145 |
| 2021 | 4,173 | 162 | None | 11% | $1,588,755 |
| 2020 | 3,804 | 158 | None | None | $1,356,987 |
| 2019 | 3,421 | 149 | None | 11% | $1,074,269 |
| 2018 | 1,605 | 119 | None | 16% | $649,822 |
| 2017 | 283 | 41 | None | None | $166,490 |
| 2016 | 344 | 55 | 0% (0) | None | $172,088 |
| 2015 | 862 | 78 | None | 24% | $372,210 |
| 2014 | 1,175 | 86 | None | 21% | $712,789 |
| 2013 | 2,038 | 89 | None | 27% | $1,355,320 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 45 drugs
| Posaconazole | 113 | $393,759 | $3,485 |
| Cresemba | 25 | $104,785 | $4,191 |
| Itraconazole | 198 | $92,693 | $468 |
| Prevymis | 12 | $88,798 | $7,400 |
| Atovaquone | 45 | $46,155 | $1,026 |
| Valganciclovir | 115 | $31,881 | $277 |
| Everolimus | 27 | $19,288 | $714 |
| Advair Diskus | 25 | $13,213 | $529 |
| Eliquis | 16 | $10,707 | $669 |
| Jardiance | 11 | $10,621 | $966 |
| Tacrolimus | 114 | $9,228 | $81 |
| Clotrimazole | 97 | $7,537 | $78 |
| Acyclovir | 217 | $4,345 | $20 |
| Mycophenolate Mofetil | 42 | $3,642 | $87 |
| Pantoprazole | 265 | $3,562 | $13 |
| Nystatin | 64 | $3,229 | $50 |
| Sulfamethoxazole-Trimethoprim | 249 | $2,748 | $11 |
| Azithromycin | 109 | $2,066 | $19 |
| Rosuvastatin | 105 | $1,771 | $17 |
| Prednisone | 159 | $1,657 | $10 |
| Diltiazem 24hr Er (Cd) | 13 | $1,272 | $98 |
| Pravastatin | 60 | $1,128 | $19 |
| Metoprolol | 98 | $1,008 | $10 |
| Amlodipine Besylate | 81 | $830 | $10 |
| Mirtazapine | 44 | $690 | $16 |
| Fluticasone Propionate | 38 | $617 | $16 |
| Warfarin | 43 | $537 | $12 |
| Potassium Chloride | 27 | $454 | $17 |
| Famotidine | 36 | $440 | $12 |
| Levetiracetam | 13 | $435 | $33 |
| Levothyroxine | 43 | $431 | $10 |
| Escitalopram | 29 | $405 | $14 |
| Gabapentin | 26 | $390 | $15 |
| Armour Thyroid | 11 | $360 | $33 |
| Losartan | 20 | $346 | $17 |
| Ondansetron Odt | 12 | $314 | $26 |
| Carvedilol | 18 | $313 | $17 |
| Alendronate | 27 | $307 | $11 |
| Tamsulosin | 31 | $265 | $9 |
| Atorvastatin | 21 | $207 | $10 |
| Glipizide Er | 19 | $180 | $9 |
| Furosemide | 35 | $179 | $5 |
| Omeprazole | 23 | $121 | $5 |
| Amoxicillin | 20 | $55 | $3 |
| Hydrochlorothiazide | 13 | $12 | $1 |
2022: 47 drugs
| Posaconazole | 123 | $391,624 | $3,184 |
| Cresemba | 35 | $234,023 | $6,686 |
| Itraconazole | 204 | $117,898 | $578 |
| Zarxio | 30 | $50,217 | $1,674 |
| Valganciclovir | 132 | $39,537 | $300 |
| Atovaquone | 32 | $27,759 | $867 |
| Eliquis | 36 | $19,719 | $548 |
| Tacrolimus | 171 | $17,688 | $103 |
| Advair Diskus | 28 | $13,450 | $480 |
| Clotrimazole | 157 | $11,818 | $75 |
| Everolimus | 19 | $10,774 | $567 |
| Symbicort | 12 | $8,788 | $732 |
| Acyclovir | 224 | $7,025 | $31 |
| Mycophenolate Mofetil | 54 | $5,463 | $101 |
| Pantoprazole | 292 | $3,990 | $14 |
| Sps | 13 | $3,452 | $266 |
| Cyclosporine Modified | 13 | $2,714 | $209 |
| Sulfamethoxazole-Trimethoprim | 309 | $2,269 | $7 |
| Sodium Polystyrene Sulfonate | 22 | $2,200 | $100 |
| Nystatin | 44 | $2,046 | $47 |
| Azithromycin | 99 | $1,930 | $19 |
| Prednisone | 202 | $1,775 | $9 |
| Ursodiol | 11 | $1,701 | $155 |
| Rosuvastatin | 69 | $1,473 | $21 |
| Warfarin | 60 | $1,212 | $20 |
| Pravastatin | 72 | $1,131 | $16 |
| Mirtazapine | 40 | $1,073 | $27 |
| Diltiazem 24hr Er (Cd) | 12 | $1,031 | $86 |
| Potassium Chloride | 35 | $796 | $23 |
| Levetiracetam | 20 | $698 | $35 |
| Metoprolol | 76 | $659 | $9 |
| Amlodipine Besylate | 103 | $645 | $6 |
| Tamsulosin | 54 | $572 | $11 |
| Gabapentin | 37 | $568 | $15 |
| Furosemide | 51 | $566 | $11 |
| Fluticasone Propionate | 42 | $470 | $11 |
| Levothyroxine | 44 | $470 | $11 |
| Alendronate | 44 | $371 | $8 |
| Atorvastatin | 38 | $325 | $9 |
| Omeprazole | 28 | $208 | $7 |
| Famotidine | 20 | $176 | $9 |
| Carvedilol | 17 | $163 | $10 |
| Glipizide Er | 16 | $146 | $9 |
| Ondansetron Odt | 12 | $108 | $9 |
| Losartan | 26 | $107 | $4 |
| Trazodone | 16 | $95 | $6 |
| Amoxicillin | 26 | $82 | $3 |
2021: 57 drugs
| Posaconazole | 144 | $598,557 | $4,157 |
| Creon | 18 | $160,712 | $8,928 |
| Itraconazole | 273 | $146,338 | $536 |
| Zenpep | 14 | $116,054 | $8,290 |
| Atovaquone | 81 | $78,555 | $970 |
| Cresemba | 13 | $69,187 | $5,322 |
| Valganciclovir | 195 | $47,659 | $244 |
| Tacrolimus | 187 | $26,919 | $144 |
| Eliquis | 47 | $26,513 | $564 |
| Everolimus | 27 | $17,294 | $641 |
| Clotrimazole | 163 | $14,127 | $87 |
| Advair Diskus | 31 | $13,546 | $437 |
| Symbicort | 21 | $10,524 | $501 |
| Novolog Flexpen | 17 | $9,762 | $574 |
| Breo Ellipta | 21 | $8,125 | $387 |
| Sps | 25 | $7,584 | $303 |
| Pantoprazole | 345 | $4,744 | $14 |
| Mycophenolate Mofetil | 47 | $3,859 | $82 |
| Cyclosporine Modified | 23 | $3,208 | $139 |
| Enoxaparin | 22 | $2,999 | $136 |
| Acyclovir | 244 | $2,868 | $12 |
| Azithromycin | 151 | $2,697 | $18 |
| Prednisone | 289 | $2,601 | $9 |
| Wixela Inhub | 13 | $2,409 | $185 |
| Sulfamethoxazole-Trimethoprim | 326 | $2,369 | $7 |
| Nystatin | 54 | $1,933 | $36 |
| Rosuvastatin | 71 | $1,610 | $23 |
| Pravastatin | 93 | $1,096 | $12 |
| Potassium Chloride | 59 | $1,092 | $19 |
| Sodium Polystyrene Sulfonate | 13 | $975 | $75 |
| Metoprolol | 130 | $767 | $6 |
| Ventolin Hfa | 13 | $739 | $57 |
| Mirtazapine | 24 | $726 | $30 |
| Warfarin | 46 | $685 | $15 |
| Azathioprine | 19 | $678 | $36 |
| Levetiracetam | 16 | $594 | $37 |
| Tamsulosin | 43 | $574 | $13 |
| Diltiazem 24hr Er (Cd) | 15 | $546 | $36 |
| Levothyroxine | 32 | $524 | $16 |
| Amlodipine Besylate | 79 | $521 | $7 |
| Fluticasone Propionate | 46 | $441 | $10 |
| Atorvastatin | 56 | $435 | $8 |
| Furosemide | 51 | $425 | $8 |
| Famotidine | 40 | $393 | $10 |
| Omeprazole | 23 | $284 | $12 |
| Ondansetron Odt | 19 | $219 | $12 |
| Alendronate | 41 | $215 | $5 |
| Gabapentin | 24 | $189 | $8 |
| Losartan | 34 | $185 | $5 |
| Ondansetron | 18 | $169 | $9 |
| Carvedilol | 12 | $137 | $11 |
| Ketoconazole | 12 | $136 | $11 |
| Metoclopramide | 13 | $125 | $10 |
| Loperamide | 13 | $120 | $9 |
| Sertraline | 15 | $116 | $8 |
| Sotalol | 12 | $95 | $8 |
| Fluoxetine | 12 | $78 | $7 |
2020: 53 drugs
| Posaconazole | None | 72 | $375,027 | $5,209 |
| Itraconazole | None | 308 | $181,194 | $588 |
| Zenpep | None | 18 | $133,203 | $7,400 |
| Noxafil | None | 16 | $82,376 | $5,148 |
| Valganciclovir | None | 175 | $72,216 | $413 |
| Atovaquone | None | 69 | $62,729 | $909 |
| Gammagard Liquid | Immune globulin | 16 | $41,764 | $2,610 |
| Zortress | None | 30 | $24,944 | $831 |
| Clotrimazole | None | 206 | $24,917 | $121 |
| Tacrolimus | None | 174 | $17,740 | $102 |
| Eliquis | None | 30 | $16,953 | $565 |
| Everolimus | None | 26 | $13,527 | $520 |
| Cefoxitin | None | 41 | $10,431 | $254 |
| Symbicort | None | 16 | $8,148 | $509 |
| Amitiza | None | 11 | $5,170 | $470 |
| Advair Diskus | None | 12 | $4,882 | $407 |
| Mycophenolate Mofetil | None | 61 | $4,786 | $78 |
| Pantoprazole | None | 303 | $3,951 | $13 |
| Amikacin Sulfate | None | 11 | $3,644 | $331 |
| Acyclovir | None | 229 | $2,790 | $12 |
| Azithromycin | None | 145 | $2,458 | $17 |
| Sps | None | 14 | $2,403 | $172 |
| Prednisone | None | 278 | $1,999 | $7 |
| Pravastatin | None | 123 | $1,716 | $14 |
| Sulfamethoxazole-Trimethoprim | None | 284 | $1,574 | $6 |
| Enoxaparin | None | 13 | $1,374 | $106 |
| Sodium Polystyrene Sulfonate | None | 19 | $1,367 | $72 |
| Nystatin | None | 32 | $1,213 | $38 |
| Diltiazem 24hr Er (Cd) | None | 18 | $787 | $44 |
| Rosuvastatin | None | 37 | $687 | $19 |
| Metoprolol | None | 107 | $552 | $5 |
| Warfarin | None | 40 | $533 | $13 |
| Hydralazine | None | 16 | $392 | $24 |
| Atorvastatin | None | 36 | $350 | $10 |
| Azathioprine | None | 24 | $339 | $14 |
| Amlodipine Besylate | None | 72 | $316 | $4 |
| Levothyroxine | None | 20 | $315 | $16 |
| Alendronate | None | 56 | $314 | $6 |
| Potassium Chloride | None | 18 | $267 | $15 |
| Sodium Chloride | None | 36 | $243 | $7 |
| Tamsulosin | None | 25 | $242 | $10 |
| Famotidine | None | 49 | $221 | $5 |
| Furosemide | None | 34 | $211 | $6 |
| Levetiracetam | None | 12 | $186 | $15 |
| Losartan | None | 26 | $163 | $6 |
| Omeprazole | None | 25 | $162 | $6 |
| Metoclopramide | None | 14 | $158 | $11 |
| Gabapentin | None | 25 | $141 | $6 |
| Fluticasone Propionate | None | 21 | $128 | $6 |
| Loperamide | None | 11 | $101 | $9 |
| Amoxicillin | None | 18 | $73 | $4 |
| Glipizide | None | 13 | $57 | $4 |
| Fluoxetine | None | 13 | $52 | $4 |
2019: 50 drugs
| Noxafil | 62 | $319,221 | $5,149 |
| Itraconazole | 262 | $159,836 | $610 |
| Zenpep | 15 | $101,957 | $6,797 |
| Atovaquone | 59 | $64,430 | $1,092 |
| Valganciclovir | 173 | $59,844 | $346 |
| Posaconazole | 13 | $48,633 | $3,741 |
| Zortress | 21 | $22,369 | $1,065 |
| Tacrolimus | 128 | $11,294 | $88 |
| Clotrimazole | 147 | $10,829 | $74 |
| Advair Diskus | 20 | $10,251 | $513 |
| Colistimethate | 11 | $8,490 | $772 |
| Cefoxitin | 27 | $5,534 | $205 |
| Sirolimus | 18 | $5,049 | $281 |
| Mycophenolate Mofetil | 59 | $3,880 | $66 |
| Azithromycin | 193 | $2,991 | $15 |
| Fluticasone-Salmeterol | 13 | $2,858 | $220 |
| Pantoprazole | 195 | $2,526 | $13 |
| Enoxaparin | 12 | $2,127 | $177 |
| Cyclosporine Modified | 17 | $1,896 | $112 |
| Potassium Chloride | 31 | $1,458 | $47 |
| Prednisone | 246 | $1,435 | $6 |
| Sulfamethoxazole-Trimethoprim | 316 | $1,419 | $4 |
| Pravastatin | 117 | $1,303 | $11 |
| Acyclovir | 162 | $1,093 | $7 |
| Sodium Polystyrene Sulfonate | 12 | $917 | $76 |
| Alendronate | 111 | $630 | $6 |
| Sodium Chloride | 26 | $517 | $20 |
| Nystatin | 13 | $490 | $38 |
| Hydroxyzine | 20 | $446 | $22 |
| Levothyroxine | 24 | $446 | $19 |
| Gabapentin | 28 | $446 | $16 |
| Tamsulosin | 30 | $433 | $14 |
| Metoprolol | 77 | $404 | $5 |
| Diltiazem 24hr Er (Cd) | 12 | $330 | $27 |
| Amlodipine Besylate | 83 | $295 | $4 |
| Metoprolol | 20 | $286 | $14 |
| Fluticasone Propionate | 24 | $260 | $11 |
| Omeprazole | 23 | $259 | $11 |
| Mirtazapine | 20 | $232 | $12 |
| Famotidine | 50 | $232 | $5 |
| Levofloxacin | 16 | $171 | $11 |
| Rosuvastatin | 20 | $167 | $8 |
| Atorvastatin | 28 | $138 | $5 |
| Furosemide | 20 | $113 | $6 |
| Hydralazine | 12 | $104 | $9 |
| Escitalopram | 20 | $101 | $5 |
| Ranitidine | 15 | $92 | $6 |
| Warfarin | 12 | $84 | $7 |
| Amoxicillin | 20 | $73 | $4 |
| Trazodone | 14 | $45 | $3 |
2018: 32 drugs
| Noxafil | 28 | $157,562 | $5,627 |
| Zenpep | 13 | $131,182 | $10,091 |
| Valganciclovir | 119 | $86,950 | $731 |
| Sporanox | 30 | $45,561 | $1,519 |
| Itraconazole | 85 | $42,484 | $500 |
| Zortress | 13 | $11,733 | $903 |
| Colistimethate | 14 | $11,103 | $793 |
| Tacrolimus | 73 | $9,077 | $124 |
| Clotrimazole | 61 | $4,093 | $67 |
| Incruse Ellipta | 11 | $3,608 | $328 |
| Potassium Chloride | 19 | $2,093 | $110 |
| Mycophenolate Mofetil | 30 | $1,908 | $64 |
| Ventolin Hfa | 26 | $1,449 | $56 |
| Azithromycin | 61 | $943 | $15 |
| Pantoprazole | 77 | $899 | $12 |
| Gabapentin | 44 | $683 | $16 |
| Pravastatin | 51 | $656 | $13 |
| Sulfamethoxazole-Trimethoprim | 133 | $629 | $5 |
| Prednisone | 82 | $479 | $6 |
| Fluticasone Propionate | 34 | $373 | $11 |
| Acyclovir | 65 | $373 | $6 |
| Alendronate | 56 | $351 | $6 |
| Metoprolol | 12 | $240 | $20 |
| Amlodipine Besylate | 52 | $236 | $5 |
| Metoprolol | 33 | $172 | $5 |
| Amiodarone | 11 | $149 | $14 |
| Furosemide | 28 | $136 | $5 |
| Omeprazole | 14 | $88 | $6 |
| Clonidine | 12 | $59 | $5 |
| Trazodone | 15 | $59 | $4 |
| Famotidine | 11 | $51 | $5 |
| Amoxicillin | 15 | $47 | $3 |
2017: 4 drugs
| Valganciclovir | 45 | $69,477 | $1,544 |
| Clotrimazole | 12 | $1,179 | $98 |
| Prednisone | 21 | $217 | $10 |
| Sulfamethoxazole-Trimethoprim | 12 | $44 | $4 |
2016: 8 drugs
| Valganciclovir | 30 | $53,885 | $1,796 |
| Valcyte | 13 | $18,370 | $1,413 |
| Itraconazole | 33 | $11,663 | $353 |
| Spiriva | 13 | $4,424 | $340 |
| Omeprazole | 20 | $464 | $23 |
| Azithromycin | 17 | $425 | $25 |
| Prednisone | 17 | $140 | $8 |
| Amlodipine Besylate | 12 | $23 | $2 |
2015: 26 drugs
| Valganciclovir | 37 | $93,836 | $2,536 |
| Sporanox | 27 | $34,590 | $1,281 |
| Atovaquone | 14 | $22,156 | $1,583 |
| Itraconazole | 43 | $18,355 | $427 |
| Zortress | 15 | $12,107 | $807 |
| Advair Diskus | 27 | $10,144 | $376 |
| Clotrimazole | 26 | $4,785 | $184 |
| Tacrolimus | 42 | $4,783 | $114 |
| Ursodiol | 13 | $3,618 | $278 |
| Piperacillin-Tazobactam | 11 | $2,628 | $239 |
| Mycophenolate Mofetil | 24 | $986 | $41 |
| Pravastatin | 45 | $860 | $19 |
| Duloxetine | 13 | $659 | $51 |
| Pantoprazole | 24 | $620 | $26 |
| Azithromycin | 23 | $473 | $21 |
| Prednisone | 37 | $369 | $10 |
| Polyethylene Glycol 3350 | 14 | $333 | $24 |
| Sulfamethoxazole-Trimethoprim | 23 | $329 | $14 |
| Famotidine | 41 | $256 | $6 |
| Levothyroxine | 11 | $243 | $22 |
| Omeprazole | 22 | $243 | $11 |
| Acyclovir | 19 | $185 | $10 |
| Gabapentin | 13 | $169 | $13 |
| Zolpidem | 11 | $67 | $6 |
| Glipizide | 15 | $63 | $4 |
| Alendronate | 12 | $57 | $5 |
2014: 31 drugs
| Valcyte | 48 | $283,598 | $5,908 |
| Voriconazole | 20 | $53,547 | $2,677 |
| Itraconazole | 66 | $28,776 | $436 |
| Sporanox | 20 | $20,076 | $1,004 |
| Enoxaparin | 16 | $15,183 | $949 |
| Tacrolimus | 61 | $11,114 | $182 |
| Mycophenolate Mofetil | 34 | $2,053 | $60 |
| Clotrimazole | 29 | $2,038 | $70 |
| Gabapentin | 35 | $1,564 | $45 |
| Pravastatin | 41 | $717 | $17 |
| Pantoprazole | 33 | $618 | $19 |
| Levofloxacin | 13 | $606 | $47 |
| Polyethylene Glycol 3350 | 16 | $584 | $37 |
| Prednisone | 66 | $535 | $8 |
| Acyclovir | 42 | $477 | $11 |
| Pen Needles | 16 | $405 | $25 |
| Azathioprine | 13 | $373 | $29 |
| Omeprazole | 27 | $364 | $13 |
| Sulfamethoxazole-Trimethoprim | 57 | $353 | $6 |
| Diltiazem 24hr Cd | 17 | $352 | $21 |
| Mirtazapine | 13 | $231 | $18 |
| Famotidine | 37 | $211 | $6 |
| Alendronate | 29 | $199 | $7 |
| Clonidine | 23 | $159 | $7 |
| Warfarin | 14 | $148 | $11 |
| Zolpidem | 16 | $128 | $8 |
| Metoprolol | 11 | $110 | $10 |
| Furosemide | 16 | $54 | $3 |
| Glipizide | 12 | $46 | $4 |
| Ranitidine | 11 | $41 | $4 |
| Atenolol | 12 | $29 | $2 |
2013: 40 drugs
| Valcyte | 110 | $568,417 | $5,167 |
| Voriconazole | 44 | $102,681 | $2,334 |
| Sporanox | 103 | $100,719 | $978 |
| Creon | 16 | $47,967 | $2,998 |
| Mepron | 26 | $42,903 | $1,650 |
| Zenpep | 12 | $36,522 | $3,043 |
| Itraconazole | 43 | $28,282 | $658 |
| Tacrolimus | 107 | $24,107 | $225 |
| Advair Diskus | 35 | $14,077 | $402 |
| Clotrimazole | 123 | $10,321 | $84 |
| Novolog Flexpen | 21 | $6,019 | $287 |
| Combivent Respimat | 18 | $4,727 | $263 |
| Mycophenolate Mofetil | 56 | $3,531 | $63 |
| Azithromycin | 53 | $2,560 | $48 |
| Pantoprazole | 83 | $2,203 | $27 |
| Omeprazole | 67 | $1,378 | $21 |
| Pravastatin | 84 | $1,261 | $15 |
| Diltiazem Er | 19 | $1,228 | $65 |
| Pen Needles | 28 | $1,195 | $43 |
| Acyclovir | 91 | $1,094 | $12 |
| Sulfamethoxazole-Trimethoprim | 133 | $1,002 | $8 |
| Bupropion Hcl Sr | 12 | $839 | $70 |
| Polyethylene Glycol 3350 | 16 | $749 | $47 |
| Prednisone | 104 | $667 | $6 |
| Fluticasone Propionate | 31 | $610 | $20 |
| Alendronate | 61 | $553 | $9 |
| Ventolin Hfa | 12 | $509 | $42 |
| Tamsulosin | 20 | $486 | $24 |
| Gabapentin | 16 | $458 | $29 |
| Ursodiol | 12 | $381 | $32 |
| Mirtazapine | 27 | $354 | $13 |
| Amlodipine Besylate | 25 | $292 | $12 |
| Diltiazem 24hr Cd | 12 | $291 | $24 |
| Zolpidem | 32 | $232 | $7 |
| Famotidine | 20 | $176 | $9 |
| Atorvastatin | 11 | $164 | $15 |
| Citalopram Hbr | 11 | $146 | $13 |
| Furosemide | 19 | $77 | $4 |
| Atenolol | 15 | $39 | $3 |
| Folic Acid | 12 | $25 | $2 |
Money from drug and device companies
$2,006 in 2025
| 2025 | 4 | 11 | None | $2,006 |
| 2024 | 2 | 2 | None | $171 |
| 2023 | 2 | 2 | None | $560 |
| 2021 | 1 | 1 | None | $17 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| TransMedics | Organ Care System | $1,222 | 2 payments
|
| Polarean | Xenoview | $344 | 1 payment
|
| La Jolla Pharmaceutical | Giapreza | $330 | 6 payments
|
| Kamada | Cytogam | $110 | 2 payments
|
See all 11 published payments
| TransMedics | Travel · 2025-11-03 | Organ Care System | $1,044 |
| TransMedics | Travel · 2025-10-28 | Organ Care System | $178 |
| La Jolla Pharmaceutical | Meals · 2025-08-04 | Xacduro | $42 |
| La Jolla Pharmaceutical | Meals · 2025-08-04 | Giapreza | $34 |
| La Jolla Pharmaceutical | Meals · 2025-08-04 | Giapreza | $101 |
| La Jolla Pharmaceutical | Travel · 2025-08-04 | Giapreza | $11 |
| La Jolla Pharmaceutical | Travel · 2025-08-04 | Giapreza | $5 |
| Kamada | Meals · 2025-05-17 | Cytogam | $32 |
| Kamada | Meals · 2025-05-17 | Cytogam | $79 |
| Polarean | Meals · 2025-04-29 | Xenoview | $344 |
| La Jolla Pharmaceutical | Meals · 2025-04-26 | Giapreza | $136 |
See earlier years (2024, 2023, 2021)
2024: $171
| Paragonix Technologies | Sherpapak | $122 | 1 payment
|
| Kamada | Cytogam | $49 | 1 payment
|
2023: $560
| TransMedics | Organ Care System | $439 | 1 payment
|
| La Jolla Pharmaceutical | Giapreza | $121 | 1 payment
|
2021: $17
| Sunovion Pharmaceuticals | Gemtesa | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1285776161
- Licence
- CA C51712California C51712: Current · expires 2028-04-30
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00C517120
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2007-02-13
- NPI last updated
- 2024-10-16
- NPI record certified
- 2024-10-16
This is when the NPI record was last certified, not a medical board exam.